Key facts
- Notable investors include Shenyang Science and Technology Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Yuanchu Technology (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuanchu Technology (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuanchu Technology (Biotechnology)
Manufacturer of advanced biotechnology intended to drive progress in stem cell and genetic research for medical and wellness applications. The company offers stem cell therapies, genetic diagnostics, biomedical software, and regenerative healthcare products, enabling hospitals, research institutes, and individual consumers to access personalized medicine and enhanced health outcomes.
- Sector
- Healthcare
- HQ
- Shenyang, China
- Founded
- 2014
- Ownership
- Privately Held (backing)
Yuanchu Technology (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuanchu Technology (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuanchu Technology (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.